173 related articles for article (PubMed ID: 38740862)
1. Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model.
Takase EO; Yamasaki R; Nagata S; Watanabe M; Masaki K; Yamaguchi H; Kira JI; Takeuchi H; Isobe N
Sci Rep; 2024 May; 14(1):10877. PubMed ID: 38740862
[TBL] [Abstract][Full Text] [Related]
2. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
[TBL] [Abstract][Full Text] [Related]
3. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
Front Immunol; 2018; 9():2588. PubMed ID: 30464764
[TBL] [Abstract][Full Text] [Related]
4. Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis.
Brand-Schieber E; Werner P; Iacobas DA; Iacobas S; Beelitz M; Lowery SL; Spray DC; Scemes E
J Neurosci Res; 2005 Jun; 80(6):798-808. PubMed ID: 15898103
[TBL] [Abstract][Full Text] [Related]
5. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
6. Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis.
Zhao Y; Yamasaki R; Yamaguchi H; Nagata S; Une H; Cui Y; Masaki K; Nakamuta Y; Iinuma K; Watanabe M; Matsushita T; Isobe N; Kira JI
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2160-2169. PubMed ID: 31932428
[TBL] [Abstract][Full Text] [Related]
7. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB
J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738
[TBL] [Abstract][Full Text] [Related]
8. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Markoullis K; Sargiannidou I; Gardner C; Hadjisavvas A; Reynolds R; Kleopa KA
Glia; 2012 Jul; 60(7):1053-66. PubMed ID: 22461072
[TBL] [Abstract][Full Text] [Related]
9. Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis.
Kwakowsky A; Chawdhary B; de Souza A; Meyer E; Kaye AH; Green CR; Stylli SS; Danesh-Meyer H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139284
[TBL] [Abstract][Full Text] [Related]
10. Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Grygorowicz T; Wełniak-Kamińska M; Strużyńska L
Mol Cell Neurosci; 2016 Jul; 74():1-9. PubMed ID: 26921791
[TBL] [Abstract][Full Text] [Related]
11. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
12. The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Lavrnja I; Savic D; Bjelobaba I; Dacic S; Bozic I; Parabucki A; Nedeljkovic N; Pekovic S; Rakic L; Stojiljkovic M
J Pharmacol Sci; 2012; 119(3):221-32. PubMed ID: 22785017
[TBL] [Abstract][Full Text] [Related]
13. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
[TBL] [Abstract][Full Text] [Related]
14. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
[TBL] [Abstract][Full Text] [Related]
15. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM
Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863
[TBL] [Abstract][Full Text] [Related]
16. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG
Teixeira NB; Sant'Anna MB; Giardini AC; Araujo LP; Fonseca LA; Basso AS; Cury Y; Picolo G
Brain Behav Immun; 2020 Feb; 84():253-268. PubMed ID: 31843645
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Savarin C; Hinton DR; Valentin-Torres A; Chen Z; Trapp BD; Bergmann CC; Stohlman SA
J Neuroinflammation; 2015 Apr; 12():79. PubMed ID: 25896970
[TBL] [Abstract][Full Text] [Related]
18. Nav1.5 in astrocytes plays a sex-specific role in clinical outcomes in a mouse model of multiple sclerosis.
Pappalardo LW; Samad OA; Liu S; Zwinger PJ; Black JA; Waxman SG
Glia; 2018 Oct; 66(10):2174-2187. PubMed ID: 30194875
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
20. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
